Autopsy report · NCT01316445

Pharmacodynamics of Nasal and Buccal Midazolam Using EEG

“Funding agency no longer provide support.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 months before it started.
• Ran for about 2 years 7 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Columbia University

Sponsor type

University, hospital or other

Conditions

Epilepsy

Interventions

nasal Midazolam

Participants

9

Sites

1

Countries

United States

Trials that died the same way

• ARTerial EMbolization for haemorrhoIdal Disease (ART.EM.I. Study)
  “Funding no longer available.” (79% match in meaning)
• Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS
  “No funding support” (71% match in meaning)
• Muscle, Essential Amino Acids, and eXercise in Heart Failure
  “There is no longer any funding to support the study” (71% match in meaning)
• Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy
  “no longer had funding to continue” (71% match in meaning)
• Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production
  “Funding discontinued” (70% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.